Drugplain

Leader All Day Sinus and Cold D 220 mg/1

Naproxen sodium, Pseudoephedrine HCl · TABLET, FILM COATED, EXTENDED RELEASE · Cardinal Health 110, LLC. dba Leader

No Recall History
Plain English

Leader All Day Sinus and Cold D is an over-the-counter tablet containing naproxen sodium (a pain reliever and anti-inflammatory) and pseudoephedrine (a decongestant) to help relieve sinus congestion, headache, and cold symptoms. The extended-release formulation is designed to provide symptom relief throughout the day.

Key Facts

Brand Name
Leader All Day Sinus and Cold D
Generic Name
Naproxen sodium, Pseudoephedrine HCl
NDC Code (Product)
70000-0605
Manufacturer
Cardinal Health 110, LLC. dba Leader
Strength
220 mg/1
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Marketing Status
Application #
ANDA076518
Marketing Start
05/19/2022

Recall History

No Recall History

Frequently Asked Questions

What is Leader All Day Sinus and Cold D used for?

Leader All Day Sinus and Cold D is an over-the-counter tablet containing naproxen sodium (a pain reliever and anti-inflammatory) and pseudoephedrine (a decongestant) to help relieve sinus congestion, headache, and cold symptoms. The extended-release formulation is designed to provide symptom relief throughout the day.

Is Leader All Day Sinus and Cold D a controlled substance?

Leader All Day Sinus and Cold D is not classified as a controlled substance by the DEA.

What is the generic name for Leader All Day Sinus and Cold D?

The generic name for Leader All Day Sinus and Cold D is Naproxen sodium, Pseudoephedrine HCl. There are 3 other brand versions of Naproxen sodium, Pseudoephedrine HCl.

What is the NDC code for Leader All Day Sinus and Cold D 220 mg/1?

The NDC (National Drug Code) for Leader All Day Sinus and Cold D 220 mg/1 is 70000-0605, listed by Cardinal Health 110, LLC. dba Leader.

Product NDC

70000-0605

Package NDC

70000-0605-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)